Christian Camani

Christian Camani is a seasoned investor with a broad portfolio of engagements across various companies. Currently, Christian serves as an investor at Turn2X, Veesion, ONWARD, PathoQuest, Threatray, Attolight, AVAtronics, Biograil™, Wildbiene + Partner, and InterAx Biotech. With a Master's degree in Business Administration (MBA) from the University of St.Gallen, earned between 1987 and 1992, Christian Camani brings extensive expertise and experience to the investment landscape.